Pharmacological Considerations in the Management of Infection-Associated Hemophagocytic Lymphohistocytosis

Tuesday, October 14, 2025 · 7:00 p.m. · Eastern Time (US & Canada)

Who can view: Everyone

Webinar Price: Free

Featured Presenters

Alpha Zeta Omega

VIEW CHANNEL CONTACT

Documents

Recommended

.js-disable-section{ top: 0px; left: 5%; position: fixed; width: 90%; height: auto; margin: 0px; padding: 0px; z-index: 9999999; } .js-bme-box{ box-shadow: rgba(0, 0, 0, 0.1) 0px 2px 4px; background-color: rgb(255, 0, 0); border-color: darkred; color: rgb(255, 255, 255); background-image: linear-gradient(to right, rgb(255, 49, 110), rgb(245, 53, 113)); border-radius: 0px 0px 5px 5px; text-align: center; } .js-bme-box span{ font-size: 18px; text-align: center; padding: 13px 10px; position: relative; font-family: 'ModernSans', Arial, Helvetica, sans-serif; font-weight: normal; line-height: 50px; } #register_with_pre_response, #register_with_pre_response_template, #submit_registration_button{ pointer-events:none !important; opacity: 0.5 !important; }

Javascript is required to complete registration. Please enable Javascript in your browser, or contact support for instruction on how to do so.

Pharmacological Considerations in the Management of Infection-Associated Hemophagocytic Lymphohistocytosis

Pharmacological Considerations in the Management of Infection-Associated Hemophagocytic Lymphohistocytosis

Jessica Filippoli, MPH

Felicia Wang, PharmD

Alpha Zeta Omega